Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. - Wikidata - wikimedia - TriplyDB

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

http://www.wikidata.org/entity/Q34535592

about

The metabolic syndrome in Africa: Current trends Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio.Genomic and metabolomic profile associated to microalbuminuria.Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study.Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population.Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.The increasing impact of laboratory medicine on clinical cardiology.Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy.Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients.Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice.Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women.Microalbuminuria in primary hypertension: a guide to optimal patient management?Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Chronic kidney disease as a predictor of clinical risk in the elderly.Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension.Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.

P2860

Q24605049-2A114019-3F09-4D97-9950-F6D398E6848D Q30479094-D5223ED0-FBAA-48A4-8F5E-1B78CCBA594D Q33707463-14F1B32A-E595-4A25-9B8D-57B37AA620E3 Q33740729-DF236A04-CCCA-4C39-8A51-6C49A962EA16 Q34472658-F3D2452A-465C-48E2-A98A-D40DBE0FE890 Q34750931-E98ED09E-22A3-42F8-A1B1-F9CEF9B8A8C9 Q34785219-C832E5F0-807F-4B3E-9585-39DF1EEB8D20 Q35129591-596758C8-D2D9-4200-BBBD-AAB6DF728004 Q35206514-42F041B7-8DC5-4E95-BE96-764025DC97E8 Q36191289-C80F8F01-32C3-4EF7-BAA5-371DF1499200 Q36359500-A1975716-B892-4BE7-9664-E828F2784162 Q36596862-27229E28-D63F-437A-8411-D569B95F0891 Q36729160-AC25668F-51C0-4B3D-9134-5011AF7F2DE5 Q36736656-5DC82D43-6F90-4278-BAB7-6AC1831B3777 Q37207281-2A93CC62-BBD6-4074-B88F-32A49C00BB21 Q37600007-C5D52C38-67FE-4765-BB90-C167B48FE1C5 Q38897199-FF3439F1-5CC2-45B5-992D-1B732B2ACE8C Q39165618-896B0460-A8DF-48BA-B4ED-DCC11A865773 Q40012728-568CE32E-74B4-4D2A-952B-69D366A48E4F Q44701846-253748F7-F8D1-4D39-A2E7-8929DF11BF90 Q52880307-05570176-7B91-49D7-9518-AA2F44679B64

P2860

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

http://www.wikidata.org/entity/Q34535592

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@ast

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@en

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@nl

type

label

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@ast

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@en

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@nl

prefLabel

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@ast

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@en

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@nl

P1433

Q34535592-643CEB2E-484B-43FC-A1D3-3E6D4C6ED9C5

P1476

Q34535592-450F9C2E-30EB-4E80-BF10-8F150CFBECE2

P2093

Q34535592-1D4EB2A5-2E2F-410E-9653-8600948D6870

Q34535592-A72D620B-9494-4542-A185-D18BF661D419

Q34535592-B463AFA2-647B-472A-935B-B57124A1AF39

Q34535592-F84FDB47-9247-443D-9EC4-660FB9BED6A5

Q34535592-F9212392-983C-4E0E-8335-8F3F377C6913

P2860

Q34535592-01B99658-7E7F-4FA9-9E41-87DC4904D188

Q34535592-040CAD37-7BC7-4A43-84D5-A4F60C417785

Q34535592-041B592A-29BC-4175-9339-E2B3621E192D

Q34535592-05C25B1D-C90E-4489-A4C4-F57BCEC97592

Q34535592-0D4C63DA-9A9A-409F-B8C4-9D2243D010DD

Q34535592-0D91206B-3EC6-4A00-8AF0-BCE1A350954A

Q34535592-0F4A2A59-E623-4DEE-984E-2434B31F5BC0

Q34535592-0F6AB874-F3E2-403A-AE5F-399FAC5D9527

Q34535592-108A4793-AB76-494A-9D2A-66A32CE48769

Q34535592-15D5644B-227C-470A-B3CA-550E05A318FF

P2888

Q34535592-D711A82B-469B-47A7-AC16-9107EAE20B64

P304

Q34535592-A8D34522-99D8-4EE6-BDDD-E5F032237E56

P31

Q34535592-7F34DDF4-DC47-4BFD-9280-8AA1F1C6E066

P356

Q34535592-0F17093E-8966-494A-860A-B9AFED038722

P433

Q34535592-325A54E9-D04E-45CB-9384-F1F26C6A0F7B

P478

Q34535592-973A78D9-9F1A-4CA1-9548-980B43DC2396

P577

Q34535592-E8A8E33C-E167-486C-A8EB-D4A80A92D3C7

P5875

Q34535592-3955E507-9AC8-4CB9-A355-F5769E12F2B9

P6179

Q34535592-12F06FEE-7F4D-4272-AACC-820EB87C86C9

P698

Q34535592-B85E3203-614F-4584-A54A-B326AE4DBC7B

P921

Q34535592-AD0FE63A-744A-4AB0-B36B-F43CA2A648CA

P356

P1433

Journal of Human Hypertension

P1476

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.

@en

P2093

Dell'Omo G

http://www.w3.org/2001/XMLSchema#string

Di Bello V

http://www.w3.org/2001/XMLSchema#string

Mariani M

http://www.w3.org/2001/XMLSchema#string

Pedrinelli R

http://www.w3.org/2001/XMLSchema#string

Pontremoli R

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project.

Insulin resistance and human disease: a short history.

Prognostic value of ambulatory blood pressure : current evidence and clinical implications.

Cigarette smoking, endothelial injury and cardiovascular disease.

Prognostic implications of left ventricular hypertrophy.

Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease.

Microalbuminuria: associations with height and sex in non-diabetic subjects.

Microalbuminuria: a genetic link between diabetes and cardiovascular disease?

Dual effect of insulin on plasma volume and transcapillary albumin transport.

P2888

P304

79-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.JHH.1001316

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11510221

http://www.w3.org/2001/XMLSchema#string

P6179

1027260331

http://www.w3.org/2001/XMLSchema#string

P698

11850764

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio